Assembly Biosciences (ASMB) Change in Account Payables (2014 - 2026)
Assembly Biosciences (ASMB) recorded quarterly Change in Account Payables of -$42000.0 in Q1 2026, up 91.8% quarter-over-quarter from -$512000.0 in Q4 2025, and down 114.48% on a YoY basis from $290000.0 in Q1 2025.
Assembly Biosciences (ASMB) Change in Account Payables (2014 - 2026) Analysis & Trends
Assembly Biosciences' Change in Account Payables history runs 13 years deep, the most recent figure standing at -$42000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 114.48% year-over-year to -$42000.0; the TTM figure through Mar 2026 stood at $254000.0 (up 71.62% YoY), while the FY2025 annual figure was $586000.0, up 372.58% from the prior year.
- Change in Account Payables was -$42000.0 for Q1 2026 at Assembly Biosciences, up from -$512000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.0 million in Q2 2022 to a low of -$1.3 million in Q1 2023.
- Historically, Change in Account Payables has averaged -$90000.0 across 5 years, with a median of -$132000.0 in 2025.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables jumped 1677.42% in 2022, then plunged 278.38% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $551000.0 in 2022, then slumped by 153.9% to -$297000.0 in 2023, then slumped by 152.53% to -$750000.0 in 2024, then surged by 31.73% to -$512000.0 in 2025, then jumped by 91.8% to -$42000.0 in 2026.
- The last three Change in Account Payables figures came in at -$42000.0 (Q1 2026), -$512000.0 (Q4 2025), and $940000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | -42,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42,000.00 |
| Mar 31, 2026 | -42,000.00 |
| Dec 31, 2025 | -512,000.00 |
| Dec 31, 2025 | -512,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Sep 30, 2025 | 940,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Mar 31, 2025 | 290,000.00 |
| Dec 31, 2024 | -750,000.00 |
| Dec 31, 2024 | -750,000.00 |
| Sep 30, 2024 | 534,000.00 |
| Sep 30, 2024 | 534,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Mar 31, 2024 | 266,000.00 |
| Dec 31, 2023 | -297,000.00 |
| Dec 31, 2023 | -297,000.00 |